All the news Showing 10 of 39 articles from: Harm reduction interventions and policyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Low dead-space syringes associated with lower hepatitis C prevalence in people who inject drugs Keith Alcorn / 01 October 2018 Exclusive use of low dead-space syringes is associated with a lower prevalence of hepatitis C virus (HCV) in people who inject drugs, especially in people who began injecting drugs recently, a study ... Supervised drug consumption sites offer opportunities for HCV testing and treatment Liz Highleyman / 02 August 2018 Most supervised drug consumption facilities offer hepatitis C virus (HCV) testing and referrals, but very few offer treatment, indicating that they could potentially play a greater role in curbing transmission and negative health ... Scotland’s reduction in new HCV infections due to harm reduction, not treatment Keith Alcorn / 12 June 2018 The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and ... Harm reduction measures for HCV prevention and treatment lacking in Europe's prisons, survey finds Keith Alcorn / 31 May 2018 Harm reduction measures for the prevention and treatment of hepatitis C in prisoners are still lacking in the majority of European countries and the lack of harm reduction will block ... Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy Keith Alcorn / 12 April 2018 An eight-week course of sofosbuvir/velpatasvir (Epclusa) cured almost all people with hepatitis C genotype 3 without cirrhosis receiving treatment alongside opioid substitution therapy through community pharmacies or prisons in the Greater Glasgow area, ... Harm reduction scale-up needed to eliminate HCV in people who inject drugs, European model predicts Keith Alcorn / 01 February 2018 Elimination of hepatitis C among people who inject drugs in Europe will require simultaneous scale-up of direct-acting antiviral treatment, needle and syringe programmes (NSP) and opioid substitution therapy (OST), and ... Does drug injection equipment other than syringes transmit hepatitis C? Liz Highleyman / 19 September 2017 Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in The Journal of Infectious Diseases. In an experiment designed ... Indonesian buyers club helps people obtain generic hepatitis C treatment Liz Highleyman / 30 May 2017 A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral (DAA) drugs to treat hepatitis C and is seeing a high cure rate, according to a ... New hepatitis C infections tripled in US over the past five years Liz Highleyman / 22 May 2017 The US Centers for Disease Control and Prevention (CDC) released new data last week showing that the number of new hepatitis C virus (HCV) infections reported to the agency nearly tripled between 2010 ... Few young people with HCV in the US live close to needle-exchange services Michael Carter / 11 May 2017 The vast majority (80%) of young people with hepatitis C virus (HCV) infection in the United States have to travel at least ten miles to access needle exchange programmes, investigators report in the ... ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive